Michael Donnelly
m.donnelly.1@research.gla.systa-s.com
Research title: PDE4 PROTACS as novel therapeutics
Research summary
Using first-in-class PDE4 targeting PROteolysis-TArgeting Chimeras (PROTACs) to selectively target abberant expression of PDE4s in neurodegenerative diseases and cancers.